Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
66.40    -0.10 (-0.15%)
Bid:
65.80
Ask:
66.50
Spread: 0.70 (1.064%)
Market Cap: £586.60m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Transaction in Own Shares

29 Jan 2025 07:00

RNS Number : 0132V
IP Group PLC
29 January 2025
 

Transaction in Own Shares

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited (which is trading for these purposes as Deutsche Numis) ("Deutsche Numis"), purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme, an extension to which was announced on 09 January 2025 (the Buyback Programme).

Date of purchase:

28/01/2025

Number of ordinary shares purchased:

380,000

Highest price paid per ordinary share (GBp):

52.00

Lowest price paid per ordinary share (GBp): 

51.10

Volume weighted average price paid per ordinary share (GBp): 

51.6084

 

Any Ordinary Shares purchased under the Buyback Programme will be cancelled in order to decrease the number of Ordinary Shares in issue. Accordingly, following the above transaction and subsequent cancellation of the Repurchased Shares, the Group has 968,838,125 ordinary shares in issue with voting rights. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules. There are no Ordinary Shares held in treasury.

 

IP Group will make further announcements following the completion of any additional purchases pursuant to the Buyback Programme.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Deutsche Numis on behalf of IP Group as part of the Buyback Programme.

 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

 

Aggregate information:

 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

 

Date of purchases:

28/01/2025

Number of ordinary shares purchased:

380,000

Volume weighted average price (pence):

51.6084

 

Individual transactions:

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Trading venue

10905

51.10

 09:27:54

XLON

10174

51.10

 09:27:54

XLON

71

51.30

 09:56:27

XLON

71

51.30

 09:56:27

XLON

10456

51.30

 09:56:27

XLON

11393

51.30

 10:01:02

XLON

12880

51.10

 10:01:07

XLON

2025

51.50

 10:38:51

XLON

1076

51.50

 10:38:51

XLON

10359

51.60

 10:41:51

XLON

9886

51.50

 10:49:34

XLON

4745

51.50

 11:31:48

XLON

2830

51.50

 11:31:48

XLON

4243

51.60

 11:31:53

XLON

33

51.60

 11:31:53

XLON

9620

51.50

 12:11:05

XLON

2123

51.50

 12:11:05

XLON

6728

51.50

 12:11:05

XLON

3043

51.40

 12:17:58

XLON

3830

51.40

 12:29:39

XLON

4000

51.40

 12:29:39

XLON

4799

52.00

 13:30:14

XLON

5108

52.00

 13:30:14

XLON

12393

52.00

 13:30:14

XLON

9895

51.90

 13:31:58

XLON

11500

51.80

 13:31:59

XLON

633

51.80

 13:31:59

XLON

9996

51.80

 13:38:36

XLON

11529

51.80

 13:38:36

XLON

10874

51.60

 14:30:09

XLON

2071

51.60

 14:41:09

XLON

2155

51.60

 14:41:09

XLON

1298

51.60

 14:41:09

XLON

3201

51.60

 14:44:34

XLON

7577

51.60

 14:44:34

XLON

1963

51.70

 14:44:34

XLON

1590

51.70

 14:44:34

XLON

1996

51.70

 14:44:34

XLON

2108

51.70

 14:44:34

XLON

3195

51.70

 14:44:34

XLON

10887

51.60

 14:47:53

XLON

1812

51.90

 15:02:43

XLON

1840

51.90

 15:02:43

XLON

2773

51.90

 15:02:43

XLON

10369

51.90

 15:09:43

XLON

10369

51.80

 15:09:43

XLON

11480

51.70

 15:12:51

XLON

10409

51.60

 15:26:13

XLON

506

51.70

 15:38:03

XLON

2357

51.70

 15:38:03

XLON

11380

51.70

 15:38:03

XLON

9917

51.60

 15:38:04

XLON

1605

51.60

 15:45:33

XLON

1967

51.60

 15:45:33

XLON

1779

51.60

 15:45:33

XLON

1918

51.60

 15:45:33

XLON

2133

51.60

 15:45:33

XLON

1056

51.60

 15:51:53

XLON

1056

51.60

 15:51:53

XLON

8790

51.60

 15:51:53

XLON

287

51.60

 16:03:05

XLON

6166

51.60

 16:03:05

XLON

10339

51.60

 16:04:14

XLON

419

51.70

 16:04:14

XLON

4800

51.70

 16:04:14

XLON

1861

51.70

 16:04:14

XLON

1863

51.70

 16:04:14

XLON

3420

51.70

 16:04:14

XLON

10794

51.70

 16:14:14

XLON

5995

51.70

 16:17:26

XLON

5281

51.70

 16:17:26

XLON

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Portland

Alex Donaldson

+44 (0) 7516 729702

 

Further information on IP Group is available on our website: www.ipgroupplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSKZGZMVRNGKZM
Date   Source Headline
16th Jun 20267:00 amRNS-RIstesso starts trial of leramistat in sarcopenia
11th Jun 20267:00 amRNSHolding(s) in Company
3rd Jun 20267:00 amRNSHolding(s) in Company
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
28th May 20267:00 amRNSHolding(s) in Company
13th May 20265:30 pmRNSNotice of AGM
12th May 20269:10 amRNS-REnterprise reports positive results from P2 trial
11th May 20264:25 pmRNSHolding(s) in Company
11th May 20264:19 pmRNSHolding(s) in Company
7th May 20267:00 amRNSAppointment of Chair Designate
23rd Apr 202612:18 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNS-RFirst Light announces £25m successful first close
15th Apr 20265:00 pmRNSAnnual Financial Report
14th Apr 20269:25 amRNSHolding(s) in Company
30th Mar 20262:00 pmRNSNew climate fund launch with Australia's CEFC
26th Mar 202610:00 amRNSHolding(s) in Company
25th Mar 20262:00 pmRNSHolding(s) in Company
19th Mar 20265:30 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSIP Group plc 2025 Annual Results Release
17th Mar 20267:00 amRNSIP Group plc 2025 Annual Results Release
13th Mar 20265:45 pmRNSHolding(s) in Company
12th Mar 202611:00 amRNSHolding(s) in Company
12th Mar 20269:00 amRNSNotice of Results
12th Mar 20269:00 amRNSNotice of Results
4th Mar 20267:00 amRNS-RPortfolio company Oxa raises $103m in Series D
26th Feb 20262:53 pmRNSHolding(s) in Company
26th Feb 20269:30 amRNSHolding(s) in Company
25th Feb 20265:51 pmRNSHolding(s) in Company
11th Feb 20269:01 amRNS-RMicrobiotica announces positive P1b trial results
30th Jan 20267:00 amRNSHolding(s) in Company
29th Jan 20267:00 amRNSHolding(s) in Company
20th Jan 202612:36 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSDirectorate change
14th Jan 20267:00 amRNSHolding(s) in Company
12th Jan 20266:25 pmRNSHolding(s) in Company
7th Jan 20262:06 pmRNSPulmocide announces termination of Phase 3 study
2nd Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20255:26 pmRNSHolding(s) in Company
4th Dec 20254:13 pmRNSHolding(s) in Company
1st Dec 20255:37 pmRNSTotal Voting Rights
20th Nov 20257:00 amRNSCompletion of share buyback programme
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20251:10 pmRNSArtios completes oversubscribed $115m financing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.